Advanced search

5 '-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New adenosine A(1) receptor antagonists and inverse agonists.

(2002) JOURNAL OF MEDICINAL CHEMISTRY. 45(9). p.1845-1852
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Calenbergh, Serge, A LINK, S FUJIKAWA, R DE LIGT, Veerle Vanheusden, A GOLISADE, NM BLATON, J ROZENSKI, AP IJZERMAN, and Piet Herdewijn. 2002. “5  ’-Deoxy Congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New Adenosine A(1) Receptor Antagonists and Inverse Agonists.” Journal of Medicinal Chemistry 45 (9): 1845–1852.
APA
Van Calenbergh, S., LINK, A., FUJIKAWA, S., DE LIGT, R., Vanheusden, V., GOLISADE, A., BLATON, N., et al. (2002). 5  ’-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New adenosine A(1) receptor antagonists and inverse agonists. JOURNAL OF MEDICINAL CHEMISTRY, 45(9), 1845–1852.
Vancouver
1.
Van Calenbergh S, LINK A, FUJIKAWA S, DE LIGT R, Vanheusden V, GOLISADE A, et al. 5  ’-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New adenosine A(1) receptor antagonists and inverse agonists. JOURNAL OF MEDICINAL CHEMISTRY. 2002;45(9):1845–52.
MLA
Van Calenbergh, Serge, A LINK, S FUJIKAWA, et al. “5  ’-Deoxy Congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New Adenosine A(1) Receptor Antagonists and Inverse Agonists.” JOURNAL OF MEDICINAL CHEMISTRY 45.9 (2002): 1845–1852. Print.
@article{149613,
  author       = {Van Calenbergh, Serge and LINK, A and FUJIKAWA, S and DE LIGT, R and Vanheusden, Veerle and GOLISADE, A and BLATON, NM and ROZENSKI, J and IJZERMAN, AP and Herdewijn, Piet},
  issn         = {0022-2623},
  journal      = {JOURNAL OF MEDICINAL CHEMISTRY},
  language     = {eng},
  number       = {9},
  pages        = {1845--1852},
  title        = {5 '-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N-6-cyclopentyladenine: New adenosine A(1) receptor antagonists and inverse agonists.},
  volume       = {45},
  year         = {2002},
}

Web of Science
Times cited: